[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370525-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370525-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comparing-eq-5d-5l-and-ipos-among-residents-with-malignant-tumors-in-a-community-home-hospice-a-longitudinal-study","Comparing EQ-5D-5L and IPOS - among residents with malignant tumors in a community home hospice - a longitudinal study","","This longitudinal study evaluates the feasibility and measurement properties of the EuroQol 5-Dimension 5-level (EQ-5D-5L) and the Integrated Palliative care Outcome Scale (IPOS) for residents with malignant tumors in a Japanese community home hospice. Two-wave data were collected from 120 residents across 2021–2023 at admission, one week after admission, and at condition change. EQ-5D-5L showed high feasibility, while IPOS had moderate feasibility with more missing data. Both scales showed low ceiling/floor effects; EQ-5D-5L had low responsiveness and IPOS moderate responsiveness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comparing-eq-5d-5l-and-ipos-among-residents-with-malignant-tumors-in-a-community-home-hospice-a-longitudinal-study/370525/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comparing-eq-5d-5l-and-ipos-among-residents-with-malignant-tumors-in-a-community-home-hospice-a-longitudinal-study/370525.png","ImageObject",300,407,{"name":42,"@type":43},"WPS_1786070896","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",17,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this study?","Question",{"text":63,"@type":64},"To compare the measurement properties and feasibility of EQ-5D-5L and IPOS in community home hospice residents with malignant tumors, using data grounded in real home hospice application.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were EQ-5D-5L and IPOS administered and when were data collected?",{"text":68,"@type":64},"Residents completed both measures upon admission. Data were gathered at three time points: admission, one week after admission, and when residents’ conditions changed.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key feasibility and responsiveness findings?",{"text":72,"@type":64},"EQ-5D-5L showed high feasibility, whereas IPOS showed moderate feasibility with a higher missing data rate. EQ-5D-5L had low responsiveness, while IPOS had moderate responsiveness.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370525,1790470446,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Miura et al. BMC Palliative Care (2025) 24:134 [https://doi.org/10.1186/s12904-025-01779-2](https://doi.org/10.1186/s12904-025-01779-2)  \nBMC Palliative Care  \n RESEARCH Open Access  \nComparing EQ-5D-5L and IPOS  \namong residents with malignant tumorsin a community home hospice: a longitudinal study  \nTakeshi Miura 1,2*, Masato Kaneko 1, Kei Kawano2,3, Yuka Kanoya2 and Makoto Kuroki 1  \nAbstract  \nBackground In community home hospices, limited medical staff and high workloads necessitate measurement models that objectively and effectively capture the needs of residents with malignant tumors. This study compares the measurement properties and feasibility of the EuroQol 5-Dimension 5-level (EQ-5D-5L) and Integrated Palliative care Outcome Scale (IPOS), primarily used in palliative care, as only few studies have compared their measurement properties and feasibility based on their actual application in home hospice care.  \nMethods Two-wave longitudinal data were collected from 2021 to 2023 at a community home hospice in Japan from a sample of 120 residents diagnosed with malignant tumors. Residents completed both the EQ-5D-5L and IPOS upon admission. Data were collected at three main time points: the initial admission date, one week after admission, and when residents’ conditions changed. This study evaluates the feasibility and measurement properties of EQ-5D-5Land IPOS, including ceiling and floor effects, correlations among domains, and responsiveness.  \nResults The EQ-5D-5L demonstrated high feasibility, whereas the IPOS had moderate feasibility with a higher missing data rate. Both scales had low ceiling and floor effects. The EQ-5D-5L showed low responsiveness, while the IPOS showed moderate responsiveness. Anxiety and the emotional domains ofthe IPOS or EQ-5D-5L scores were insignificantly correlated. Participants who did not complete the IPOS had significantly lower EQ-5D-5L scores.  \nConclusions The EQ-5D-5L may be slightly more suitable for the primary screening of needs in this setting owing to its higher feasibility. In contrast, the IPOS is an excellent tool when it is important to comprehensively and deeply capture the needs of individuals over time. We note that when selecting or using different measures, one must consider the specific characteristics of each measure.  \nKeywords Palliative care, Patient reported outcome measures, Hospice care, Quality of life, Integrated Palliative care Outcome Scale, EuroQol 5-Dimension 5-level  \n*Correspondence:  \nTakeshi Miura  \n[miura.tak.cq@yokohama-cu.ac.jp](miura.tak.cq@yokohama-cu.ac.jp)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025, corrected publication 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nMiura et al. BMC Palliative Care (2025) 24:134  \nBackground  \nPalliative care is considered essential in healthcare, especially with an aging population and","cbCainfMDlow7dHR","https://ap.wps.com/l/cbCainfMDlow7dHR","pdf",749428,11,"English","# Abstract\n# Background\n## Need for person-centered palliative care\n## Role of community-home hospices\n## Importance of patient-reported outcome measures","[{\"question\":\"What is the main objective of this study?\",\"answer\":\"To compare the measurement properties and feasibility of EQ-5D-5L and IPOS in community home hospice residents with malignant tumors, using data grounded in real home hospice application.\"},{\"question\":\"How were EQ-5D-5L and IPOS administered and when were data collected?\",\"answer\":\"Residents completed both measures upon admission. Data were gathered at three time points: admission, one week after admission, and when residents’ conditions changed.\"},{\"question\":\"What were the key feasibility and responsiveness findings?\",\"answer\":\"EQ-5D-5L showed high feasibility, whereas IPOS showed moderate feasibility with a higher missing data rate. EQ-5D-5L had low responsiveness, while IPOS had moderate responsiveness.\"}]","Comparing EQ-5D-5L and IPOS - among residents with malignant tumors in a community home hospice - a longitudinal study | PDF",1790188963,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/602d13d1cb3149fbbcba4fe5b8120d35.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd61a23fa582fd2169d17c2f3d897ba1.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/557a0b7655dbfdc7154f998002b34357.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/388922d1168e5f828f5bccf47b41157c.webp",980,1301]